Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 08.05.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
08.05.24Northern Data Group - Continued progress as a diversified HPC provider439Northern Data Group demonstrated progress made in Q124 alongside a capital markets day update, as it takes further steps in becoming a diversified high-performance computing (HPC) infrastructure solutions...
► Artikel lesen
08.05.24Oryzon Genomics - Doubling down on clinical activity in 2024313Oryzon's Q124 results emphasised the company's focus on advancing and expanding its CNS and oncology pipelines, driven by its core assets, vafidemstat and iadademstat. Operating performance was in line...
► Artikel lesen
08.05.24AVAX - Strong pipeline reaffirmed230AVAX's FY23 results highlight the group's progress domestically as the market improved, more than offsetting the weaker international performance at the top-line and EBITDA level. We have downgraded...
► Artikel lesen
08.05.24MGI - Media and Games Invest - A strong start to the year399MGI's Q124 report shows an impressive 21% organic revenue uplift over Q123, with both good new client recruitment and higher spend from existing clients as corporate confidence rebuilds. With the market...
► Artikel lesen
08.05.24Claranova - EBITDA improvement across all divisions715On relatively flat H124 revenue, Claranova grew adjusted EBITDA more than 50% year-on-year as the focus on profitability over growth started to deliver. With Avanquest's loss-making non-core business...
► Artikel lesen
08.05.24IRLAB Therapeutics - MSRD agreement early validation for IRL757614The McQuade Center for Strategic Research and Development (MSRD) has signed an exclusive R&D collaboration for Irlab's pre-clinical candidate IRL757, following recent clearance by Swedish authorities...
► Artikel lesen